Comparison of fingolimod and nod-like receptor protein 3 inflammasome inhibitor treatment on disease progression in experimental autoimmune encephalomyelitis model

Neuroscience Applied 2026 Open access

Read full text
Authors: A. Żochowska-Klepańska, I. Cichoń, M. Baryła, E. Sokołowska
DOI: 10.1016/j.nsa.2025.106529
Cited by: 0

Fields of Study & Subjects

Multiple Sclerosis Research Studies Inflammasome and immune disorders Systemic Lupus Erythematosus Research

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106529–106529
Publication date
1 January 2026
Language
EN